Zacks: Bel Fuse, Inc. (NASDAQ:BELFB) Given $19.00 Consensus Price Target by Analysts

Share on StockTwits

Bel Fuse, Inc. (NASDAQ:BELFB) has been given a consensus broker rating score of 2.00 (Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One analyst has rated the stock with a buy recommendation.

Brokers have set a 1-year consensus price target of $19.00 for the company, according to Zacks. Zacks has also given Bel Fuse an industry rank of 78 out of 255 based on the ratings given to its competitors.

BELFB has been the subject of a number of research analyst reports. TheStreet cut Bel Fuse from a “c” rating to a “d+” rating in a research note on Wednesday, October 30th. ValuEngine upgraded Bel Fuse from a “sell” rating to a “hold” rating in a research note on Tuesday, August 6th. Finally, Needham & Company LLC upped their price objective on shares of Bel Fuse from $17.00 to $19.00 and gave the company a “buy” rating in a report on Tuesday, November 12th.

Hedge funds and other institutional investors have recently bought and sold shares of the business. Metropolitan Life Insurance Co NY acquired a new position in shares of Bel Fuse in the first quarter valued at about $84,000. Municipal Employees Retirement System of Michigan lifted its holdings in shares of Bel Fuse by 123.7% during the second quarter. Municipal Employees Retirement System of Michigan now owns 6,600 shares of the electronics maker’s stock worth $114,000 after purchasing an additional 3,650 shares during the period. State of Alaska Department of Revenue lifted its holdings in shares of Bel Fuse by 126.8% during the third quarter. State of Alaska Department of Revenue now owns 7,748 shares of the electronics maker’s stock worth $116,000 after purchasing an additional 4,332 shares during the period. Stifel Financial Corp purchased a new stake in Bel Fuse in the third quarter valued at approximately $164,000. Finally, Barclays PLC boosted its position in Bel Fuse by 7.5% in the third quarter. Barclays PLC now owns 12,418 shares of the electronics maker’s stock valued at $185,000 after buying an additional 870 shares during the last quarter. 61.16% of the stock is owned by institutional investors and hedge funds.

NASDAQ BELFB traded up $0.63 on Tuesday, hitting $16.72. The stock had a trading volume of 90,392 shares, compared to its average volume of 39,160. The business’s fifty day moving average price is $15.32 and its 200 day moving average price is $15.22. The stock has a market cap of $205.19 million, a price-to-earnings ratio of 19.73 and a beta of 1.51. The company has a debt-to-equity ratio of 0.69, a current ratio of 3.21 and a quick ratio of 1.94. Bel Fuse has a 52-week low of $9.03 and a 52-week high of $27.77.

Bel Fuse (NASDAQ:BELFB) last posted its quarterly earnings data on Wednesday, October 30th. The electronics maker reported $0.20 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.22. Bel Fuse had a return on equity of 5.83% and a net margin of 0.31%. The firm had revenue of $124.48 million during the quarter.

The business also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Wednesday, January 15th will be paid a dividend of $0.07 per share. The ex-dividend date is Tuesday, January 14th. This represents a $0.28 dividend on an annualized basis and a yield of 1.67%.

About Bel Fuse

Bel Fuse Inc designs, manufactures, markets, and sells products that are used in the networking, telecommunication, high-speed data transmission, commercial aerospace, military, broadcasting, transportation, and consumer electronic industries in North America, Asia, and Europe. It offers magnetic products, such as integrated connector modules; power transformers; SMD power inductors and SMPS transformers; and telecom discrete components.

Recommended Story: Most Volatile Stocks

Get a free copy of the Zacks research report on Bel Fuse (BELFB)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Bel Fuse Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bel Fuse and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.